Why building a compliant company is the smartest investment for market access in Brazil

For many organizations, product registration is seen as the first milestone on the path to entering the Brazilian market. In reality, successful market access begins much earlier.

A solid regulatory foundation is not simply a legal requirement—it is a strategic business asset. Companies that prioritize regulatory planning from the outset reduce operational risks, accelerate approvals, protect investments, and create a sustainable platform for long-term growth.

Compliance failures can stop a business overnight

Recent enforcement actions issued by the Brazilian Health Regulatory Agency (ANVISA) illustrate a recurring problem across regulated industries. Several companies had their products prohibited, seized, and removed from the market because they lacked the required operating authorization and attempted to commercialize products without the appropriate regulatory approval.

These cases reinforce an important lesson:

A compliant product cannot exist without a compliant company behind it.

Attempting to shorten the path to commercialization by bypassing regulatory requirements rarely saves time. Instead, it creates significant legal exposure, operational interruptions, financial losses, and reputational damage.

Build the company before launching the product

Every regulatory strategy should begin with corporate compliance.

Before submitting any product for regulatory review, companies must establish the appropriate legal, technical, and quality infrastructure required by Brazilian authorities.

Depending on the business model, this process may include:

• Developing the sanitary project;
• Appointing the Responsible Technical Professional (RT);
• Implementing a robust Quality Management System (QMS);
• Obtaining the local Health License;
• Securing ANVISA’s Operating Authorization (AFE);
• Achieving Good Manufacturing Practice (GMP) or Good Storage and Distribution Practice certifications whenever applicable.

Only after these foundational elements are in place does product registration become a secure and predictable process.

The critical transition that many companies underestimate

The period between corporate licensing and product registration is often where the greatest regulatory challenges emerge.

Medical devices, cosmetics, sanitizing products, in vitro diagnostics, pharmaceuticals, and other regulated products require careful classification, technical assessment, and compliance with complex regulatory frameworks.

A single mistake during this stage can result in unnecessary delays, additional costs, requests for clarification, or even rejection of the application.

Strategic regulatory assessment before submission significantly reduces these risks and improves the overall efficiency of the approval process.

Regulatory consulting should create business value

Regulatory affairs should never be viewed as a purely administrative function.

When integrated into business strategy, regulatory intelligence becomes a competitive advantage—supporting faster market entry, reducing uncertainty, strengthening compliance, and enabling confident business expansion.

At Register Medical Group, we combine regulatory expertise with strategic business thinking.

Our multidisciplinary team supports companies throughout every stage of their regulatory journey, including:

• Corporate regulatory structuring;
• Licensing and operating authorizations;
• Quality Management Systems implementation;
• Regulatory strategy development;
• Product registration and lifecycle management;
• Ongoing compliance support.

Our mission extends beyond obtaining approvals.

We help organizations build resilient regulatory frameworks that support innovation, operational excellence, and sustainable growth.

Compliance is the foundation of sustainable market access

Successful companies understand that regulatory compliance is not an obstacle to growth—it is one of its strongest enablers.

Investing in the right regulatory strategy from the beginning protects your business, preserves your reputation, minimizes operational risks, and creates a faster, safer path to the Brazilian market.

At Register Medical Group, we transform regulatory complexity into strategic advantage, helping companies navigate Brazil’s healthcare regulatory landscape with confidence, efficiency, and long-term vision.